May 3-6 Rotterdam, Netherlands
LBVeP-1 | Technical refinements of RAPID technique: continuing innovation in a cutting-edge procedure | Umberto Cillo | Received |
FvP-1 | Training the Next Generation of Transplant Surgeons with 3D hands-on liver models | Jorge Sanchez-Garcia | Received |
VeP-1 | Robotic right hepatectomy and portal vein resection for HCC with portal vein tumor thrombosis | Paolo Magistri | Received |
eP-001 | Robotic versus open liver resection for HCC | Paolo Magistri | Received |
FP-001 | Estimating the Lifespan Following Paediatric Liver Transplantation: Is a Near-Normal Life Expectancy Attainable and What Factors Influence It? | Nicholas Syn | Received |
VeP-2 | Gallbladder saving operation in laparoscopic living donor extended left hemihepatectomy | Kyung-Suk Suh | Received |
FvP-2 | Liver Transplantation Using the Aborted Liver Graft with Re-do Pure Laparoscopic Living Donor Right Hemihepatectomy | YoungRok Choi | Received |
FP-002 | Redefining the concept of clinically significant graft steatosis in the era of automated assessment | Damiano Patrono | Received |
LBVeP-2 | Mixed-reality guided size-matching and graft reduction in paediatric living donor liver transplantation | Zong Jie Koh | Received |
eP-003 | Surgical reconstructions of hepatic artery variations for ex-situ normothermic dynamic preservation in liver transplantation | Gabriela Chullo | Received |
VeP-3 | Liver Transplantation as a Bridge for Portal Hypertension Management in Cirrhotic Patient Due to Bucrylate-Treated Variceal Infection | Christian Robles | Received |
LBVeP-3 | The use of blower- mister blower device to facilitate biliary anastamosis in living donor liver transplantation | Abhishek Yadav | Received |
FP-003 | Development of a Liver Atlas using over 1,000 consecutive deceased donor livers to identify hepatic steatosis prior to retrieval | Syed Hussain Abbas | Received |
FvP-3 | Surgical technique for Living donor Liver Transplantation with Inferior Vena Cava Replacement | Sunhawit Junrungsee | Received |
LBeP-003 | Risk Alleles of PNPLA3, TM6SF2, and HSD17B13 of Donors are Closely Related to Graft Steatosis and Steatohepatitis After Liver Transplantation | Kenta Makino | Received |
FP-004 | A systematic review and network meta-analyses on the effects of intraoperative vasopressors on postoperative outcomes in liver transplantation | François Martin Carrier | Received |
eP-004 | Liver transplantation in patients with secondary biliary cirrhosis in a Single Center | Mario Viltoba | Received |
FvP-4 | PARENCHYMAL TRANSECTION WITH HARMONIC SCALPEL IN TOTAL ROBOTIC DONOR HEPATECTOMY | FYSAL KOLLANTA VALAPPIL | Received |
LBVeP-4 | Complete IVC clearance before parenchymal transection in laparoscopic donor hepatectomy | VISHAL KUMAR CHORASIYA | Received |
LBeP-004 | M-RNA GENE EXPRESSION BY REAL-TIME REVERSE TRANSCRIPTION PCR ON LIVER BIOPSIES OF PATIENTS ENROLLED IN THE SIMVALT TRIAL: RANDOMIZED DOUBLE-BLIND CLINICAL STUDY | Duilio Pagano | Received |
FP-005 | Fabrication of human hepatic decellularized extracellular matrix derived liver scaffold A novel insight into an alternative therapy for Liver degeneration | Catherine Ann Martin | Received |
VeP-5 | Difficult Porta Dissection in Laparoscopic Donor Hepatectomy | VISHAL CHORASIYA | Received |
LBVeP-5 | Full-left/full-right liver splitting with middle hepatic vein and caval partition during dual hypothermic oxygenated machine perfusion | Alessandro Furlanetto | Received |
FvP-5 | Various retracting techniques for the laparoscopic living donor hepatectomy - double rubber extraction to facilitate liver resection | Kwang Hyun Kim | Received |
FP-006 | The effect of donor dominant one-way HLA mismatch on liver transplantation outcomes: An analysis of Korean Organ Transplantation Registry (KOTRY) database | Sunghae Park | Received |
FvP-6 | Back-Table Portal Vein and Hepatic Vein Reconstruction by Using Autologous Falciform Ligament: Video Case Sharing | Yu Cheng Lin | Received |
FvP-7 | 3D pre-operative imaging assisted transition of liver transection from CUSA to Harmonic scalpel in total robotic donor hepatectomy | Kamal Yadav | Received |
FP-007 | Genetic modification of Rat Liver Using Lentiviral Vectors During Ex Vivo Machine Perfusion | Irina CLJ Filz von Reiterdank | Received |
eP-008 | Evolution of surgical strategies in the setting of Liver Transplant (LT) for Polycystic Liver and Kidney Disease (PLKD) | Gabriela Chullo | Received |
FP-008 | Interplay Between Intrahepatic Macrophages and Alloreactive and Regulatory T-cells mediates the Complex Alloimmune Microenvironment During Acute Rejection in Clinical Liver Transplantation | Juliet Emamaullee | Received |
FvP-8 | Portal vein reconstruction in pediatric liver transplantation using end-to-side jump graft | Jae-Yoon Kim | Received |
LBeP-009 | Is It The Proper Time To Re define Small For Size Syndrome After Living Donor Liver Transplant; Opening The Pandora Box | Ahmed Zidan | Received |
eP-009 | A single center Brazilian experience of hepatic Resection After liver transplantation: results and analysis | Ronaldo Andrade | Received |
eP-010 | Upfront portal vein arterialization for complex portal vein thrombosis: a new technique that reestablish splanich system | Camila Girao | Received |
FP-010 | Carbapenemase gene detection assays Do they improve outcomes in liver transplant recipients colonised with Carbepenem resistant Enterobacteriaceae ? | Amal Francis Sam | Received |
FP-011 | Liver Transplantation Restores A Circulating Environment That Supports Healthy Platelet Aggregation Within Two Hours Of Reperfusion | Mignote Yilma | Received |
eP-011 | Novel surgical modification in piggyback technique in orthotopic liver transplantation | Dr Paramesha KN | Received |
FP-012 | Effect of Coping Skill Enhancement Therapy on Short Term Outcomes after Living Donor Liver Transplantation: A Randomized Controlled Trial | Dhananjay Saxena | Received |
eP-012 | Fibrinogen and albumin synthesis rates in upper abdominal surgery with and without major hepatectomy | Gabriel Dumitrescu | Received |
LBeP-013 | Absorbable Self-Expandable Biliary Stent as a Preventive Treatment of Biliary Complications in Liver Transplant | Pedro Antonio Lopez-Lopez | Received |
LBeP-014 | Ischemia-free liver transplantation in the rat | MASATO FUJIYOSHI | Received |
FP-014 | Evaluation of Liver Maximum Capacity (LiMAx) Measurements to Monitor Hepatocellular Function during Extended Normothermic Machine Perfusion | George Clarke | Received |
eP-014 | A review of blood utilization in a large liver transplant center after implementation of simple measures | Khoa Tran | Received |
FP-015 | Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation | Hae Won Lee | Received |
eP-015 | Applicability and prognostic value of liver frailty index in liver transplant recipients from an Indian centre | Amal Francis Sam | Received |
LBeP-015 | Early drain removal after live liver donor hepatectomy is safe - A randomized control trial | Parthiban Durairaj | Received |
LBeP-016 | Risk factors and managements of intra-operative portal vein thrombosis in living-donor liver transplantation due to biliary atresia: a single center experience from China mainland | Kai Wang | Received |
FP-016 | Early prediction of bacterial infection risk after liver transplantation for cirrhosis: the PRELINFO score | Emmanuel Weiss | Received |
eP-016 | Futility criteria of re-transplantation for Early Non-Function after liver transplantation: a retrospective multicenter study | Clara Timsit | Received |
eP-017 | Impact of cumulative fluid balance on post-operative outcomes in living donor liver transplantation | Amal Francis Sam | Received |
FP-017 | Diagnostic value and assessment of treatment efficacy of 18F-FDG PET/CT in pediatric patients with posttransplant lymphoproliferative disorder after liver transplantation | Jing-Yi Liu | Received |
LBeP-017 | Intentionally genome altered porcine livers perfused with human blood products can be sustained 72 hours ex vivo | Eliezer Katz | Received |
FP-018 | Improved Outcomes of Extended Criteria Donors in Liver Transplantation for Hepatocellular Carcinoma: A National Cohort Analysis | Elizabeth Brombosz | Received |
eP-18 | A Bimodal Distribution of Blood Loss and Blood Product Administration in Patients Undergoing Orthotopic Liver Transplantation | Nicholas Rothbard | Received |
FP-019 | The potential to develop a completely robotic living donor liver transplant surgery A systematic approach | Ramkiran Cherukuru | Received |
LBeP-019 | No association between arterial reperfusion parameters and clinical outcomes for liver transplantation using donation after circulatory death grafts | Alessandro Parente | Received |
FP-020 | Markers of Cirrhotic Cardiomyopathy May Not Improve Following Liver Transplantation | Manhal Izzy | Received |
eP-020 | Intraoperative Heparinization During Orthotopic Liver Transplantation | Christopher Wray | Received |
FP-021 | Impact of Preformed Donor-Specific Antibody Compared to that of ABO Incompatibility in Living Donor Liver Transplantation Using Propensity Score Matched Analysis | Jiyoung Kim | Received |
eP-021 | Implementation of an early extubation pathway in low-risk liver transplant recipients reduces duration of invasive mechanical ventilation and hospital resources- a quality improvement project | Stephanie Chartier-Plante | Received |
FP-022 | Identification of novel liver transplant biopsies phenotypes associated with distinct biological profiles and allograft survival | Zeynep Demir | Received |
eP-022 | Early extubation after liver transplantation has a low rate of emergent reintubation | Alessandro Galli | Received |
LBeP-022 | CXCR3 Hepatic Natural Killer Cells Promote Hepatic Ischemia-reperfusion Injury in Liver Transplantation | Xinxiang Yang | Received |
FP-023 | Potential of Mitochondrial Dysfunction Biomarkers during Ex-vivo Normothermic liver perfusion | Khaled Ali | Received |
eP-023 | Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish Cohort | Isabel Conde | Received |
FP-024 | LIVER PAIRED EXCHANGE TRANSPLANTATION: OVERCOMING THE OBSTACLES IN LIVING DONOR LIVER TRANSPLANTATION | TEVF&304;K TOLGA &350;AH&304;N | Received |
eP-024 | Risk factors for prolonged mechanical ventilation after liver transplantation | Marta Caballero | Received |
FP-025 | CALCINEURIN-INHIBITOR DISCONTINUATION CAN REDUCE THE RISK OF DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR ALCOHOL-RELATED LIVER DISEASE | Domitille Erard | Received |
eP-025 | Pretransplant coronary revascularization and patient outcome - comparing Bare Metal with Drug Eluting Stents | Vijay Vohra | Received |
eP-026 | PREDICTORS OF INTRAOPERATIVE TRANSFUSION REQUIREMENT IN ADULT LIVER TRANSPLANT RECIPIENTS | Amal Francis Sam | Received |
LBeP-026 | An Experimental Rodent Model for Long-Term Ex-Vivo Normothermic Machine Perfusion of Livers | Mark Ly | Received |
FP-026 | Hepatic Congestion-Linked Intrahepatic Biliary Stricture In The Right Liver Grafts | Hyun Hwa Choi | Received |
LBeP-027 | Insulin Secretion in Liver Transplant Recipients Following Conversion to a Prolonged Release Tacrolimus Formulation | Gerald Minuk | Received |
FP-027 | High Expression of SNGH16 is A Candidate Predictive Marker of Regional Therapy Resistance in Hepatocellular Carcinoma | Fuat Aksoy | Received |
eP-028 | Mean Systemic Filling Pressure (MSFP) trends in liver transplant recipients- a pilot study | Karthik Thirumurugan | Received |
LBeP-028 | Postoperative negative-pressure incision therapy after liver transplant (PONILITRANS study): A randomized controlled trial | Victor Lopez-Lopez | Received |
FP-028 | NON-INVASIVE DETECTION OF HYPER-METHYLATED CPG ISLANDS IN CELL-FREE DNA: A BLOOD-BASED EPIGENETIC MARKER TOOL FOR SURVEILLANCE OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS AN INTERIM ANALYSIS | Vasanthakumar Gunasekaran | Received |
eP-029 | Fast-track extubation after liver transplantation a centres evolution in practice | Arun Menon | Received |
FP-029 | Outcomes of living donor liver transplantation in acute on chronic liver failure Experience from a single center in India | Abhijith Uthaman | Received |
eP-030 | The impact of splenic artery ligation on patient outcomes and thrombocytopenia following living donor liver transplantation | Susan Paulin | Received |
LBeP-030 | Optimizing 45 Minute DCD Liver Grafts Using Stabilized Plasmin in a Static Cold Storage Orthotopic Rat Liver Transplant Model | Riley Kahan | Received |
FP-030 | Utility of novel glucagon-like peptide-1 receptor agonists as anti-obesity medications in liver transplant recipients | Seth Richardson | Received |
FP-031 | Dual hypothermic oxygenated machine perfusion (DHOPE) is associated with improved recovery of acute kidney injury (AKI) after donation after circulatory death liver transplantation | Femke de Goeij | Received |
eP-031 | Etiologies and outcome of acute liver failure listed for liver transplantation in Switzerland | Ansgar Deibel | Received |
LBeP-031 | CELIAC TRUNK STENOSIS BY MEDIAN ARCUATE LIGAMENT IN ORTHOTOPIC LIVER TRANSPLANTATION: ANALYSIS OF BILIARY COMPLICATIONS | Flavia Feier | Received |
FP-032 | Normothermic Machine Perfusion of the Liver: Early Outcomes and Hospital Resource Utilization in a High-Volume U.S. DCD Liver Transplant Center | Chi Zhang | Received |
eP-032 | IMPACT OF DONOR AGE ON OUTCOMES OF LIVING DONOR LIVER TRANSPLANT RECIPIENTS | Susan Paulin | Received |
FP-033 | Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy | Hani Wadei | Received |
eP-33 | Interim results of a mixed-methods Study Within A Trial (SWAT) to understand recruitment to a feasibility trial of octreotide infusion during liver transplantation | Edgar Brodkin | Received |
LBeP-033 | A Comparative evaluation of Thromboelastography versus Thromboelastometry for coagulopathy correction in patients of liver cirrhosis with non-variceal bleed Prospective observational study | Nimi Gopal | Received |
FP-34 | Immune response to COVID-19 vaccination in Liver transplant recipients | Dinesh Jothimani | Received |
eP-034 | Role of N-terminal pro-brain natriuretic peptide in predicting adverse outcomes in living donor liver transplant recipients | Susan Paulin | Received |
eP-036 | Challenging Case of Pediatric Liver transplant with Alagilles Syndrome with Moderate Pulmonary Stenosis | Ashish Malik | Received |
FP-036 | Pre-Transplant Donor Specific Antibodies Are Not Associated with Impaired Renal Function Post-Transplant in Simultaneous Liver-Kidney Transplant Recipients | Mozhgon Moaddab | Received |
LBeP-037 | Re-evaluating the 6 month rule prior to liver transplant: A clinical practice guideline | Joanna Dionne | Received |
eP-037 | Use of Whole Blood Transfusion During Liver Transplantation: A Retrospective Review | Samir Gandhi | Received |
FP-37 | Normothermic Mechanical Perfusion (NMP) significantly reduces the risk of ischemic cholangiopathy in recipients of donation after cardiac death (DCD) Liver Transplants | Bashar Aqel | Received |
FP-038 | A Contemporary Analysis of 20,153 Deceased Donor Liver Biopsies | Madhukar Patel | Received |
LBeP-038 | TRANSIENT ELASTOGRAPHY Vs ULTRASOUND TO DETERMINE LIVER VIABILITY FOR DONATION AND TRANSPLANTATION | Ernesto Duarte Tagles | Received |
eP-039 | Impact of preoperative hyponatremia on postoperative recovery outcomes following liver transplantation | Susan Paulin | Received |
FP-039 | Six Hundred Eighteen Consecutive Pediatric Liver Transplant: The King Faisal Hospital & Research Center Experience | Ahmed Zidan | Received |
FP-040 | Post Liver-Transplant Survival for Mixed Hepatocellular Carcinoma-Cholangiocarcinoma and Propensity-Matched Hepatocellular Carcinoma Patients | Sudha Kodali | Received |
eP-040 | Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort | Isabel Conde | Received |
eP-041 | Native whole blood (TRUE-NATEM) and recalcified citrated blood (NATEM) reference value validation with ROTEM delta | Uzung Yoon | Received |
LBeP-041 | Feasibility of enhance recovery after surgery in liver transplantation | Komal Ray | Received |
eP-042 | Liver transplantation in Amanita phalloides and acetaminophen induced acute liver failure | Emilia Kruk | Received |
eP-043 | The SATA multicenter Liver Transplant Outcomes in Anesthesia Database (Liver-TOAD): building the foundation for research collaboration in transplant anesthesia | Dieter Adelmann | Received |
LBeP-043 | The effect of Short term weight loss intervention with modified GM diet in liver donors on hepatic steatosis in living donor liver transplantation | Abhishek Yadav | Received |
eP-044 | Liver Transplantation during the COVID-19 Pandemic: Considerations and Approach in a Southeast Asian Tertiary Medical Centre | Sook Muay Tay | Received |
LBeP-044 | LIVING DONOR LIVER TRANSPLANTATION FOR ADULT PATIENTS WITH LOW MELD IN AN AREA WITH LOW RATE OF DECEASED DONATION: EUROPEAN SINGLE CENTER ANALYSIS | Duilio Pagano | Received |
eP-045 | Effect of Mechanical Ventilation on Postoperative Outcomes of Patients Undergoing Living Donor Liver Transplantation | Yu-Ling Liu | Received |
eP-46 | Portal flow modulation on trial a feasibility RCT of octreotide in liver transplant | Ilya Kantsedikas | Received |
eP-050 | Defining Tumor-Associated Macrophage Subpopulation in Intrahepatic Cholangiocarcinoma as Prognostic and Therapeutic Targets | Varvara Kirchner | Received |
eP-051 | Removal of circulating nucleosomes/neutrophil extracellular traps (NETs) reduces ex-situ reperfusion injury in porcine DCD livers preserved with normothermic machine perfusion (NMP) | Fungai Dengu | Received |
eP-052 | Histone deacetylase-11 (HDAC11) inhibitors (HDACi) are effective, novel therapy for non-alcoholic steatohapatitis (NASH) | Zhi Zhong | Received |
LBeP-053 | Changing management of type 1 Abernethy syndrome (congenital porto- caval shunt) | annalisa dolcet | Received |
eP-053 | The pro-hepato-regenerative effect of MKK4-inhibition in a preclinical porcine model of NASH | Philipp Felgendreff | Received |
LBeP-054 | Bloodstream infections after liver transplantation: risk factors and outcomes | Chih-Chi Wang | Received |
eP-056 | Formoterol, a Long-Acting 2-Adrenergic Receptor (2AR) Agonist, Stimulates Mitochondrial Biogenesis (MB) and Improves Liver Regeneration after Major Liver Resection (MLR) | Zhi Zhong | Received |
LBeP-058 | Psychological sequelae and health-related quality of life after LTx | Anke Hierundar | Received |
eP-058 | Identification of hepatocyte-restricted antigens, epitopes, and T cell receptors to treat recurrent hepatocellular carcinoma after liver transplantation | Dave Sprengers | Received |
eP-059 | Defining Metabolic changes of Human liver grafts during Long-term Normothermic Machine Perfusion | Joanna Huang | Received |
LBeP-059 | Two-stage liver resection with Rex shunt (Tr-Rex Procedure) to Augment Flow and function Prior to Right Hemihepatectomy in an adult with main Portal Vein Occlusion | Bobby VM Dasari | Received |
eP-060 | A microfluidic bile-duct-on-a-chip platform for studying biliary epithelium in a dish | Jorke Willemse | Received |
LBeP-061 | Reconstruction of Hepatic Vein by Using Falciform Ligament in Living Donor Liver Transplantation | Teng-Yuan Hou | Received |
eP-62 | Liver Resident Memory T cells are and Normothermic Liver Perfusion | David Al-Adra | Received |
LBeP-063 | Basiliximab maintenance for immunosuppression induced Haemolytic UraemicSyndrome - Thrombotic Thrombocytopenic Purpura (HUS-TTP) after Deceased Donor Liver Transplantation | Madhavi Nayak | Received |
eP-063 | Prediction of the Degree of Hepatic Ischemia-Reperfusion Injury during Normothermic Machine Perfusion Based on the Function of Multidrug Resistance-Associated Protein 2 | Joohyun Kim | Received |
eP-064 | Single Nucleus Sequencing suggests Decreased Regenerative capacity in Graft Fibrosis post-Liver Transplantation | Mamatha Bhat | Received |
LBeP-064 | Re-expansion pulmonary edema vs alveolar-pleural fistula during liver transplant: Diagnosis and management | Neal Al-Attar | Received |
eP-065 | Gene Signature Present within Background Liver Parenchyma of Transplant Recipients with Hepatocellular Carcinoma | Audrey Brown | Received |
LBeP-065 | Donation after brain death followed by circulatory death (DBCD) and a successful deceased donor liver transplant- The first case reported in Sri Lanka | Senani Samarasinghe | Received |
eP-066 | In vitro Effects of Neopterin on Invasion, Metastasis and Proliferation of Hepatocellular Cancer Cell Lines | TEVF&304;K TOLGA &350;AH&304;N | Received |
LBeP-066 | Liver transplantation during COVID-19 pandemic in Poland; numbers, indications and results | Jaroslaw Czerwinski | Received |
LBeP-067 | Gullian-Barrè Syndrome in a Liver Transplant Recipient | Madhavi Nayak | Received |
eP-068 | Hypoxia inducible factor modulation during normothermic machine perfusion (NMP) accelerates reduction in hepatic steatosis | Syed Hussain Abbas | Received |
eP-069 | DNA methylation-induced gene expression changes result in hepatic ischemia-reperfusion injury in deceased donor liver transplant recipients | Haseeb Zubair | Received |
eP-071 | Single Nucleus Sequencing reveals Hippo signaling as a Key Driver of Human Liver Regeneration | Mamatha Bhat | Received |
eP-072 | Mitochondrial-derived danger signals released during cold ischemic storage activate endothelium and influence early graft function in liver transplantation | ALBERTO BAROJA-MAZO | Received |
eP-073 | In vitro and in vivo study on Recurrence after Liver Transplantation: MALAT1 Promotes Aggressive Hepatocellular Carcinoma Proliferation, Invasion and Recurrence | Secil Ak Aksoy | Received |
eP-074 | Liver-derived MSCs Are Superior in Reducing Inflammation In Vivo | Yun Liang | Received |
eP-077 | Normothermic machine-perfused human donor livers produce functional hemostatic proteins | Silke Bodewes | Received |
eP-081 | Rejuvenation of diseased liver using gelatin-based scaffolds using the immunomodulatory property of mesenchymal stem cells. | Catherine Ann Martin | Received |
eP-084 | Testing HepatoPredict kit performance in liver transplantation prognosis for hepatocellular carcinoma when facing intra- and inter-tumoral heterogeneity | Joana Cardoso | Received |
eP-089 | NEW NON-INVASIVE MARKERS OF PORTAL HYPERFLOW AND ITS ROLE IN CIRRHOSIS AND POST-LIVER TRANSPLANT OUTCOME | Eloisa Franchi | Received |
eP-090 | Emergency Liver Retransplantation with Marginal Donors | María Josefa Cuevas | Received |
eP-091 | A new metabolic comorbidity score predicts risk of death among cirrhotic patients on waiting list for liver transplantation | Simona Parisse | Received |
eP-092 | Impact of Donor Allograft Hepatocyte Necrosis on Liver Transplant Outcomes | Chi Zhang | Received |
eP-094 | High Rate of Early HEV Seroconversion after Liver Transplantation among Cirrhotic Patients | Alessandra Mazzola | Received |
eP-95 | Predictive equations underestimate measured energy expenditure in patients awaiting liver transplant | Brooke Chapman | Received |
eP-099 | Machine learning for the prediction of long-term graft survival following liver transplantation | Katina Zheng | Received |
eP-100 | Positive antibody response in liver transplant recipients on mycophenolate mofetil after the third, fourth and fifth SARS-CoV-2 vaccination; an observational cohort study | Midas Mulder | Received |
eP-101 | FRAILTY CHANGES AFTER LIVER TRANSPLANTATION IN THE SPANISH SETTING. RESULTS FROM A SPANISH MULTICENTRE PROSPECTIVE COHORT STUDY | Lorena Puchades | Received |
eP-102 | What are risk factors for graft mortality in patients who underwent simultaneous splenectomy during living-donor liver transplantation? | Takeo Toshima | Received |
eP-103 | Assessment of silent coronary artery disease with functional and anatomic tests in liver transplantation: analysis of the diagnostic and prognostic performance of a risk-adapted protocol | Giulia Pagano | Received |
eP-104 | Phosphatidylethanol as a marker for the diagnosis of alcohol relapse after liver transplantation: single centre experience | SVETLANA ADAMCOVA SELCANOVA | Received |
eP-106 | Patient Selection Factors for Fast-Track Extubation After Adult Liver Transplantation: A Step Towards Precision Medicine in Transplantation | Gen Yi Peng | Received |
eP-107 | LONG-TERM OUTCOME OF CENTENARIAN LIVERS | Francesco Tandoi | Received |
eP-108 | Very low access to early liver Transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications | Victoria Aguilera | Received |
eP-110 | Donor atherosclerosis is the main driver of hepatic artery thrombosis after liver transplantation | Javier Manuel Zamora Olaya | Received |
eP-111 | De Novo Tumors in Liver Transplantation Recipients | Carmen BERNAL | Received |
eP-112 | 10-Year Outcomes for Patients Transplanted for Hepatocellular Carcinoma Beyond University of California, San Francisco Criteria | Sudha Kodali | Received |
eP-113 | Early major bleeding after liver transplant affects long term survival: identification of risk factors | Alessandro Galli | Received |
eP-114 | EVOLUTION AND IMPACT OF SARCOPENIA BEFORE AND AFTER LIVER TRANSPLANTATION | Jerome Dumortier | Received |
eP-116 | EFFECTIVENESS OF NOREPINEPHRINE INFUSION PROTOCOL IN ACHIEVING THE RESOLUTION OF HEPATORENAL SYNDROME | Alexandra Shingina | Received |
eP-117 | Outcomes of Adult Liver Transplantation for Acute Liver Failure; A 15-Year Experience in a Single Center | Geunhyeok Yang | Received |
eP-118 | De novo Metabolic Syndrome after Liver Transplantation: A Meta-Analysis on Cumulative Incidence, Risk Factors, and Outcomes | Wen Hui Lim | Received |
eP-119 | Open abdomen management in liver transplantation | Takanobu Hara | Received |
eP-122 | POST-TRANSPLANT OUTCOMES OF LIVER TRANSPLANT RECIPIENTS WITH HEPATIC SARCOIDOSIS: A MATCHED CASE-CONTROL STUDY | Saam Dilmaghani | Received |
eP-123 | Single-center experience with upper midline incision liver transplant (MILT): a case-matched study | Yogesh Puri | Received |
eP-124 | Impact of Cirrhotic Cardiomyopathy and its Echocardiographic Components on Intraoperative and Perioperative Outcomes after Liver Transplantation | Ashley Cozart | Received |
eP-125 | INCIDENCE OF DE NOVO SKIN AND NON-SKIN CANCER AFTER LIVER TRANSPLANTATION IN A WESTERN COUNTRY: A LONG-TERM OBSERVATIONAL STUDY | Cristina Dopazo | Received |
eP-126 | Structural and functional cardiac abnormalities in liver cirrhosis. A single-centre experience | Charles Panackel | Received |
eP-129 | Late-Onset Steatosis May Affect Post-Liver Transplant Survival in Patients with Non-Alcoholic Steatohepatitis Cirrhosis | David Victor | Received |
eP-130 | Utilization of Hepatitis C Virus-Positive Organs for Transplant: A Single-Center Experience | Sudha Kodali | Received |
eP-131 | Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A Cost-Analysis Study Using National Registries | Govind Rangrass | Received |
eP-132 | Factor V (FV) as a predictor of Graft Loss After Liver Transplant | Marco Claasen | Received |
eP-134 | A single-center analysis of gender mismatched liver transplantation in a high-volume transplant center in North America | Catherine Parmentier | Received |
eP-135 | Artificial intelligence enhanced electrocardiogram prediction of atrial arrhythmia in patients undergoing liver transplantation | Induja Reddy Nimma | Received |
eP-138 | In liver transplant recipients the humoral and cellular immune response after the 4th SARS-CoV-2 vaccination is lower than after a breakthrough infection | Martina Sterneck | Received |
eP-139 | PRIMARY SCLEROSING CHOLANGITIS AS AN INDICATION FOR LIVER TRANSPLANTATION. RESULTS AND CONDITIONING FACTORS: RELATIONSHIP WITH ASSOCIATED INTESTINAL PATHOLOGY | Ainhoa Fernández | Received |
eP-142 | Cardiac Power as a Predictor of Perioperative Outcomes in Liver Transplantation | Ruth Bickett-Hickok | Received |
eP-143 | Liver transplantation: a 10-year low-volume transplant center experience in Kazakhstan | Abylaikhan Sharmenov | Received |
eP-144 | OUTCOMES AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: INITIAL EXPERIENCE FROM VIETNAM | Dang Do Hai | Received |
eP-146 | Biliary reconstruction for multiple graft bile ducts does not impact posttransplant outcomes compared with single graft bile duct after living donor liver transplantation | Joodong Kim | Received |
eP-148 | Clinical, Demographic and Social Risk Factors Associated with COVID-19 Mortality among Liver Transplant Recipients in the United States | Yanik Bababekov | Received |
eP-149 | Clinical relevance of the interval from transplantation to therapeutic through concentrations of tacrolimus | Paloma Elma Alañón Martínez | Received |
eP-150 | The Role of Roux-en-Y Hepaticojejunostomy for the Management of Biliary Complications after Living Donor Liver Transplantation | Tzu-Cheng Wen | Received |
eP-151 | Liver Retransplantation a Twenty Year, Single Center Experience | Onur Ibanoglu | Received |
eP-152 | Distinct features and outcomes of patients with primary sclerosing cholangitis included on the waiting list for liver transplantation in Romania | Speranta Iacob | Received |
eP-153 | Perioperative Outcomes of Immediate Extubation Following Liver Transplantation: Inverse Probability of Treatment-Weighted Analyses | Gen Yi Peng | Received |
eP-154 | Left ventricular geometry is not associated with acute kidney injury following liver transplantatiojn | Peter Frasco | Received |
eP-156 | De novo and recurrence of NAFLD/NASH after liver transplantation and the impact of immunosuppressants: systematic review, meta-analysis and experimental exploration | Yining Wang | Received |
eP-157 | Combining Skeletal Muscle Index with Liver Frailty Index improves mortality prediction in patients with cirrhosis awaiting liver transplantation | Kamal Yadav | Received |
eP-158 | IS LIVER TRANSPLANTATION DIFFICULTY PREDICTIBLE ? | Simon ROUCAUTE | Received |
eP-160 | Indication of liver transplantation in the treatment of newly categorized acute-on-chronic liver failure in Japan | Kaori Kuramitsu | Received |
eP-161 | Low hepatic artery resistive index on the first post- liver transplant day is associated with inferior graft survival | Flavia Feier | Received |
eP-162 | Pregnancy and childbirth after liver transplantation in our hospital | Takashi Ito | Received |
eP-163 | Pretransplant Diabetes Mellitus Predicts Worse Outcomes of Liver Transplantation: An Updated Meta-analysis and Systematic Review | Wen Hui Lim | Received |
eP-165 | LIVER TRANSPLANTATION AFTER IVERMECTIN USE AND POST-COVID19 CHOLANGIOPATHY | Ilka Boin | Received |
eP-166 | Incidence of de novo tumors after liver Transplantation (LT) in HIV infected is similar to non-HIV patients: A Single Center Comparative Study | Carmen Vinaixa | Received |
eP-167 | Gender Impact on the Outcomes of Deceased Donor Liver Transplantation | Taryn Kedzior | Received |
eP-168 | Transjugular intrahepatic portosystemic shunt insertion as a therapy for portal hypertension improves cirrhosis-associated immune dysfunction | Penelope Hey | Received |
eP-169 | Utility of an active screening program of urine ethylglucuronide determination for confirmation of alcohol withdrawal prior to inclusion in the waiting list for liver transplantation | Patricio Más-Serrano | Received |
eP-170 | Successful Liver Transplantation in a Patient with Preoperative Takotsubos Cardiomyopathy: A Case Report | Alexandra Ruan | Received |
eP-172 | Treatment for vascular complications utilizing a hybrid operation room after liver transplantation | Hiroyuki Hakoda | Received |
eP-173 | Outcome of patients waitlisted for Deceased Donor Liver transplantation during COVID-19 pandemic - A Single centre experience | Dinesh Jothimani | Received |
eP-174 | The patient experience of the liver transplant evaluation process and potential implications related to waitlist access | Alexandra Strauss | Received |
eP-175 | Combined Coronary Artery Bypass Grafting and Living Donor Liver Transplant formidable but possible | FYSAL KOLLANTA VALAPPIL | Received |
eP-178 | DOES COLECTOMY IMPROVE SURVIVAL IN PATIENTS WITH ULCERATIVE COLITIS UNDERGOING LIVER TRANSPLANT FOR AUTOIMMUNE LIVER DISEASES? | Victoria Aguilera | Received |
eP-183 | Long-term risk of de novo solid organ malignancy: a 28-year experience oriented to living donor liver transplantation | Kosuke Tanaka | Received |
eP-186 | Liver allograft neovascularization after arterial thrombosis. Experience at the National Institute of Medical Sciences and Nutrition Salvador Zubirán in Mexico City | Catherine Parmentier | Received |
eP-187 | Hepatocellular carcinoma: segmental distribution in cirrhotic livers | Ilka Boin | Received |
eP-188 | Successful Liver Transplantation in a Patient with Alstrom Syndrome and Cardiomyopathy: A Case Report | Alexandra Ruan | Received |
eP-189 | CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatation (LT) | Victoria Aguilera | Received |
eP-190 | Safety and efficacy of Direct Oral Anticoagulants in liver transplant recipients: Initial experience | Narendra S Choudhary | Received |
eP-191 | The experience of management for biliary complication after liver transplant in small volume center | Min-Jae KIM | Received |
eP-192 | The Factors of Predicting Over-Time Weight Increase After Liver Transplantation | Yuhi Shimura | Received |
eP-193 | Combined heart liver kidney transplantation: a pioneer experience in South America | Munique Siqueira | Received |
eP-194 | The need for an artificial kidney for long-term NMP of human donor livers up to one week | Bianca Lascaris | Received |
eP-195 | Development of an Extended Liver Normothermic Machine Perfusion Protocol | George Clarke | Received |
eP-196 | N-acetylcysteine: A Novel Approach to Methaemoglobinaemia in Normothermic Liver Machine Perfusion | George Clarke | Received |
eP-197 | Outcomes of liver retransplantation from donation after circulatory death livers using normothermic regional perfusion | Christopher Watson | Received |
eP-198 | In situ and ex situ dynamic preservation versus cold storage in liver transplantation from older donation after circulatory death donors | Joris Blondeel | Received |
eP-199 | Occult fibrin in deceased donor livers is associated with transplant failure and cholangiopathy | Christopher Watson | Received |
eP-201 | Achieving Long-Term Liver Preservation: Integration of a Dialysis System to a Commercial Normothermic Perfusion System | Joanna Huang | Received |
eP-202 | The risk of microbial infection in recipients of donor livers that underwent hypothermic or normothermic machine perfusion | Chikako Endo | Received |
eP-203 | Coagulation and fibrinolysis markers during normothermic liver perfusion offer insights into vascular integrity and preservation injury | Jule Dingfelder | Received |
eP-204 | Trends and obstacles to implement dynamic perfusion concepts for clinical liver transplantation: Results from an international survey | Alessandro Parente | Received |
eP-205 | Quantified FMN perfusate levels correlate with early allograft dysfunction during hypothermic liver machine perfusion | Sertac Kacar | Received |
eP-207 | OUTCOMES OF LIVER TRANSPLANTATION WITH THORACOABDOMINAL NORMOTHERMIC REGIONAL PERFUSION FOR HEART DONATION | Luis Secanella | Received |
eP-210 | Optimization of ex vivo normothermic liver perfusion through the addition of (un)conjugated bile acids | Lianne Stevens | Received |
eP-211 | NORMOTHERMIC MACHINE PERFUSION IN HIGH-RISK EXTENDED CRITERIA DONORS: RESULTS FROM LARGE MONOCENTRIC EXPERIENCE | fabio melandro | Received |
eP-212 | Favourable outcomes with hypothermic oxygenated machine perfusion in donation after circulatory death liver transplants a single centre experience | James Walcott | Received |
eP-213 | An Add-On Automated Blood Gas System for Ex Vivo Normothermic Machine Perfusion | Daniel Babekuhl | Received |
eP-216 | Early liver transplant failure after normothermic perfusion: Not everything ends well | Rohit Gaurav | Received |
eP-218 | Proof of concept for clinical application of machine perfusion to extended criteria donor grafts in Japan | Akihiko Soyama | Received |
eP-221 | Role of pre-operative steroids on liver IRI in DCD liver transplantation | Shekhar Kubal | Received |
eP-223 | A pilot comparison of two devices for liver normothermic machine perfusion in clinical transplantation | Qiang Liu | Received |
eP-224 | Impact of Normothermic Machine Perfusion on Abdominal Transplant Fellowship Training | Mignote Yilma | Received |
eP-225 | Ex situ fibrinolytic therapy during normothermic perfusion before transplantation clears intravascular fibrin and is associated with minimal cholangiopathy | Christopher Watson | Received |
eP-226 | Hypothermic oxygenated perfusion (HOPE) using an ECMO device with FMN levels measurement and thermographic images for liver graft assessment and transplantation | Elizabeth Rivas | Received |
eP-227 | Ultra-rapid harvesting method for liver graft from donor after cardiac death | Eiji Kobayashi | Received |
eP-229 | The role of normothermic machine perfusion in large liver grafts | Beatrice Cazzaniga | Received |
eP-230 | Machine-perfusion for liver transplantation in high-volume centres versus low/mid-volume centres: an international multicentre survey | Roberta Angelico | Received |
eP-232 | Excellent Outcomes Despite Prolonged Graft Preservation Times: Early Single Center Experience with Portable Normothermic Machine Perfusion in DCD Liver Transplantation | Mark Hobeika | Received |
eP-235 | Impact of Normothermic Machine Perfusion in liver transplantation with donors after circulatory death: a single-center experience | Emmanuel Nogueira | Received |
eP-237 | Machine Perfusion Preservation of DCD livers is associated with Increased DRI: Data from the UNOS/SRTR Database | Peter Abt | Received |
eP-238 | Liver assessment method with flow dynamics index during subnormothermic machine perfusion | Hiromichi Obara | Received |
eP-239 | Impact of a novel flush method using environmental pressure control for organs from donor after cardiac death | Syuhei Yoshimoto | Received |
eP-240 | Normothermic machine perfusion preservation on livers from donors after circulatory death | Qiang Liu | Received |
eP-242 | Dual hypothermic oxygenated perfusion (D-HOPE) of liver grafts from ECD donors after brain death initial experience in the single center of Medical University of Warsaw | Piotr Niecikowski | Received |
eP-244 | VALIDATION OF MELD3.0 IN TWO CENTRES FROM DIFFERENT CONTINENTS | Marta Tejedor | Received |
eP-245 | Biomarkers during orphan liver normothermic machine perfusion: who is more reliable to predict post-transplant outcomes? | Qiang Liu | Received |
eP-246 | Performance of the Gender-Equity Model for Liver Allocation (GEMA-Na) within the first 30 and 60 days of listing | Manuel Rodríguez-Perálvarez | Received |
eP-247 | Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation based on Etiology of Liver Cirrhosis | Wen Hui Lim | Received |
eP-250 | Outcomes of Transplantation of Hepatitis B NAT Positive Organs for Hepatitis B Seronegative Recipients of Liver Transplants | Julie Giannini | Received |
eP-251 | Machine-Learning-Assisted Donor-Recipient Matching for Orthotopic Liver Transplantation | Miran Bezjak | Received |
eP-252 | Retransplantation using living donor grafts: who are reasonable applicants? | Kosuke Tanaka | Received |
eP-253 | Transplants for HCC. Do radiologists and pathologists agree? | James Vassallo | Received |
eP-254 | Outcomes of Re-Referrals for Patients With Alcohol-Related Liver Disease Who Were Previously Declined for Liver Transplantation | Benjamin Cox | Received |
eP-255 | Ethnic Disparities in Waitlist Outcomes of Non-alcoholic Steatohepatitis Listed for Liver Transplantation in the United States | Wen Hui Lim | Received |
eP-256 | National and Regional Trends in Liver Transplant Exception Points After Allocation Policy Change | Taryn Kedzior | Received |
eP-257 | Quantification of Mitochondrial Dysfunction Surrogates in Flushing Solution to Assess Donor Livers Pre Transplantation | Khaled Ali | Received |
eP-258 | ACCESS TO LIVER TRANSPLANT FOR WOMEN IN SPAIN: A NATIONAL REGISTRY ANALYSIS | Marta Tejedor | Received |
eP-259 | Impact of extended living donor crirteria on donor safety in living donor liver transplantation | Joodong Kim | Received |
eP-261 | A simple noninvasive index can predict liver graft discard in marginal donors | Sergio Cortese | Received |
eP-264 | Increasing Access to Transplantation for Hispanic Patients Through an Integrative Pilot Spanish Speaking Liver Transplant Program | Blanca Lizaola-Mayo | Received |
eP-265 | Modernizing the Concept of Donor Risk Index (DRI): DBD-DRI and DCD-DRI Scores to Predict Liver Graft Survival | Yanik Bababekov | Received |
eP-266 | Identifying Ideal Liver Candidates for Donation after Cardiac Death Transplants | Yanik Bababekov | Received |
eP-267 | A Web Calculator to Predict Progression to Cardiac Death within 30 Minutes of Potential DCD Donors Using DonorNet | Yanik Bababekov | Received |
eP-269 | Overview of liver organ allocation policies in Europe and the impact on outcome after liver transplantation | Xavier Verhelst | Received |
eP-270 | Characterization and Evolution of Caregiver Burden Among Caregivers of Liver Transplant Recipients | Kymberly Watt | Received |
eP-272 | Discrimination ability of post liver transplant mortality in acute-on-chronic liver failure: MELD-Na versus CLIF-C ACLF score | Jae Hwan Kim | Received |
eP-273 | Liver-centered acute-on-chronic liver failure is not associated with improved survival after liver transplantation | Joris Blondeel | Received |
eP-274 | Impact Of Organ Allocation Policy Change In Simultaneous Liver Kidney Organ Transplant In The Unites States: An Institutional Experience | Lydia Mercado | Received |
eP-275 | Effectiveness of DEI Committees Outreach Program at a Single Center Serving a Large Hispanic Population | Sudha Kodali | Received |
eP-276 | National Trends in Liver Transplant After Allocation Policy Change with a Focus on Diversity | Taryn Kedzior | Received |
eP-277 | Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation | Takahiro Tomiyama | Received |
eP-278 | DEMOGRAPHIC AND SOCIOECONOMIC DISPARITIES CONTINUES TO PERSIST IN PATIENTS LISTED FOR LIVER TRANSPLANTATION IN THE POST-SHARE 35 POLICY ERA | Mignote Yilma | Received |
eP-279 | Impact of the UNOS Acuity Circles Liver Allocation Policy on Waitlist Dropout at a High Volume Center | Eduardo Fernandes | Received |
eP-280 | Systematic Review and Meta-Analysis of Factors Affecting Survival after Liver Retransplantation | Elizabeth Brombosz | Received |
eP-282 | Current Practices and Perceptions of Ex Vivo Liver Machine Perfusion in the United States | Chi Zhang | Received |
eP-283 | A risk factor analysis of donor-specific factors on one- and three-year post-transplant mortality after multi visceral transplantation | Tommy Ivanics | Received |
eP-284 | Risk Factors for Mortality after Receiving a Liver Graft from an Older Donor | Elizabeth Brombosz | Received |
eP-285 | CHANGING INDICATIONS FOR LIVER TRANPLANTATION IN THE ERA OF DAA. RETROSPECTIVE ANALYSIS OF DATA OF A LIVER TRANPLANT CENTER | Donatella Pisaniello | Received |
eP-286 | Spontaneous Gall bladder rupture in a patient with Decompensated Cirrhotic identified at Transplantation | sorabh kapoor | Received |
eP-287 | ROLE OF A NURSE WITHIN AN ORGAN DONATION PROGRAMME IN THE INTENSIVE CARE UNIT | Mateja afar | Received |
eP-288 | ANALYSIS OF DONOR ORGAN FACTORS IN EARLY POST-TRANSPLANT HEPATOCARCINOMA RECURRENCE | Miguel Jimenez Perez | Received |
eP-289 | Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals | Ainhoa Fernández | Received |
eP-293 | Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients | Audrey Coilly | Received |
eP-294 | Vancomycin-Resistant Enterococcus Bloodstream Infections After Liver Transplantation | Max Adelman | Received |
eP-295 | Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: the randomized controlled FK04 trial | Bastian Ruijter | Received |
eP-298 | Long-term results of ab-initio introduction of Everolimus after liver transplantation | Domiziana Pedini | Received |
eP-299 | Eight-week post-transplant treatment of HCV-negative kidney recipients from HCV-viremic donors with glecaprevir/pibrentasvir is as effective as twelve-week treatment | Benyam Addissie | Received |
eP-300 | DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS RELATED TO IMMUNOSUPPRESSIVE REGIMEN | CARMEN ALONSO-MARTIN | Received |
eP-301 | Liver Transplantation outcomes in patients following COVID-19 infection | Radhika Venugopal | Received |
eP-302 | Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-COV-2 in the immediate post liver transplant period | Flavia Feier | Received |
eP-303 | The impact of Organ/Space Surgical Site Infections (OSSI) on outcome after deceased donor liver transplant | Femke de Goeij | Received |
eP-304 | A multi-centre non-interventional study to assess the tolerability and effectiveness of extended-release tacrolimus (LCPT) in de novo liver transplant patients | Gabriela Berlakovich | Received |
eP-305 | RESPONSE TO COVID-19 VACCINATION AND CONTIXAGEVIMAB-CILGAVIMAB PROPHYLAXIS IN PATIENTS UNDERGOING LIVER AND KIDNEY TRANSPLANTATION: PRELIMINARY STUDY | Domiziana Pedini | Received |
eP-306 | Selective intestinal decolonization and antibiotic treatment of Carbapenem-Resistant Enterobacteriaceae in pediatric and adult liver transplant recipients | Sunitha Vimalesvaran | Received |
eP-307 | Outcomes and mortality of early SARS-CoV-2 infection in liver transplant recipients of a large volume transplant center in Latin America | Jorge Arturo Martinez | Received |
eP-308 | SURVIVAL AFTER COVID-19 IN UNVACCINATED LIVER TRANSPLANT RECIPIENTS ACCORDING TO DISEASE WAVES - RESULTS FROM A BRAZILIAN MULTICENTRIC STUDY | Ilka Boin | Received |
eP-309 | Role of antithymocyte globulin based induction immunosuppression in adult liver transplantation | Shekhar Kubal | Received |
eP-310 | A Case of Mixed Chronic Rejection and Recidivism treated with Everolimus and Lifestyle Modifications | Hirak Pahari | Received |
eP-312 | Technical feasibility and outcome of Salvage living donor liver transplantation after major hepatectomy | Young-In Yoon | Received |
eP-316 | Should We Reconstruct Both Hepatic Arteries in Right Lobe Grafts with Two Hepatic Arteries? | Sung Min Kim | Received |
eP-319 | The Gift of Life in Solid Organ Transplantation: A Qualitative Systematic Review of Altruistic Living Donors Perspectives | Wen Hui Lim | Received |
eP-320 | Impact of baseline anti-ABO antibody titer on biliary complications following ABO-incompatible living donor liver transplantation | Dong-Sik Kim | Received |
eP-321 | Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With acute liver failure | DongHwan Jung | Received |
eP-322 | Effect of the response to preoperative treatment for hepatorenal syndrome on the outcome of recipients of living-donor liver transplantation | Ryugen Takahashi | Received |
eP-323 | Effect of Desensitization Protocol According to the Degree of Antibody Mediated Rejection Risk in Living Donor Liver Transplant; Retrospective Cohort Study | YoungRok Choi | Received |
eP-325 | Pre-operative percutaneous portal vein recanalization and transjugular intrahepatic portosystemic shunt makes living donor liver transplantation feasible in extensive porto-mesenteric thrombosis | Fysal Kollanta Valappil | Received |
eP-327 | SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THORACIC EPIDURAL ANALGESIA IN DONOR HEPATECTOMIES- AN EXPERIENCE OF OVER A DECADE | Nikunj Gupta | Received |
eP-329 | Initial high anti-ABO isoagglutinin titer is a major red flag of bacterial infection in ABO-incompatible living donor liver transplantation | Mun Chae Choi | Received |
eP-330 | The evolution of robotic donor hepatectomy as standard of care at a high volume living donor liver transplant center | Kamal Yadav | Received |
eP-331 | Total robotic right lobe donor hepatectomy and recipient surgery via a midline incision: small cuts no longer a big dream in living donor liver transplantation | Kamal Yadav | Received |
eP-332 | GM diet: a quick fix for steatotic live liver donors | Anish Gupta | Received |
eP-333 | Post-donation regret, family relationships, and depression in living liver donors: a mediation model | Ye Sol Lee | Received |
eP-341 | Impact of three-dimensional thoracic shape on the surgical outcomes of minimally invasive living donor hepatectomy | Kosuke Tanaka | Received |
eP-343 | Effect of adding congested segment ? to left lateral graft on short-term outcomes in pediatric living donor liver transplant recipients | Hikaru Aoki | Received |
eP-344 | Older Living Liver Donors can enlarge the Donor Pool: A Systematic Review and Meta-Analysis | Hayo Ter Burg | Received |
eP-345 | Living Donor Liver Transplant Trends in the Era of Acuity Circle Allocation in the United States | Alexandra Shingina | Received |
eP-346 | Donor BMI Has No Impact on Post-Operative Outcomes in Living Donor Liver Transplantation | Reed Jenkins | Received |
eP-347 | UTILITY OF HEPARIN PROPHYLAXIS AND PERIOPERATIVE VASCULAR THROMBOSIS AFTER PEDIATRIC LIVER TRANSPLANTATION | Ampaipan Boonthai | Received |
eP-349 | Left Lobe procurement based on intraoperative portal pressure measurement and its impact on outcome | Rajesh Dey | Received |
eP-350 | A successful rescue procedure of in situ graft volume reduction for accommodation to the small abdominal cavity during pediatric living donor liver transplantation | Yasuhiro Ogura | Received |
eP-351 | Impact of short-term weight reduction program for steatotic graft or high BMI donor on the outcome of living-donor liver transplantation | Hye-Sung Jo | Received |
eP-352 | Development of Metabolic Disorders in Liver Transplant Recipients | Gizem Erdemir | Received |
eP-354 | Perioperative risk factors for early bacteremia and sepsis following living donor liver transplantation (LDLT) | Devika Pradeep | Received |
eP-357 | Biliary strictures after pediatric living donor liver transplantation analysis of incidence, risk factors, management and outcome | Mateusz Ciopi&324;ski | Received |
eP-358 | Impact of RhD blood group mismatch in Living Donor Liver transplantation | Dinesh Jothimani | Received |
eP-359 | An intention-to-treat analysis of live donor liver transplantation vs. deceased donor liver transplantation for patients with alcoholic liver disease | Owen Jones | Received |
eP-366 | Migration of Polytetrafluoroethylene graft used for neo-middle hepatic vein reconstruction in living donor liver transplant recipients case series | Akash Selvathangam | Received |
eP-368 | Transition from open- to robot-assisted donor right hepatectomy program for adult to adult living liver donation: early outcomes and lessons learned | Michele Finotti | Received |
eP-371 | Does the option of robotic donor hepatectomy positively influence willingness for live liver donation? | Kamal Yadav | Received |
eP-372 | International Living Donor Liver Transplant Registry | LDLTregistry.org | Camila Hidalgo Salinas | Received |
eP-373 | Building a donor pool for acute liver failure through unrelated undirected donation in the Middle East | Maren Schulze | Received |
eP-374 | Aberrant Totally Extrahepatic Right Hepatic Duct in Live Liver Donors | Safa Vatansever | Received |
eP-375 | Living donor liver transplantation for samll ducts intrahepatic cholangiocarcinoma with neoadjuvant chemotherapy: a pioneer experience in South America | Munique Siqueira | Received |
eP-376 | Methylene Blue during living donor liver transplantation - Case series - | Myungsuk Kim | Received |
eP-379 | Liver Retransplantation Indications and Technical Approaches in Post Hepatitis C Era | Rolf Barth | Received |
eP-380 | Outcome of 40 LDLT in a newly established adult living donor liver transplant program in the Netherlands | Robert Minnee | Received |
eP-381 | Impact of Medicaid Expansion on Liver Transplantation in the State of Oklahoma | Taryn Kedzior | Received |
eP-383 | Obliterative portal venopathy in biliary atresia: Histology of recipient portal veins replaced during living donor liver transplantation | Muthukumarassamy Rajakannu | Received |
eP-384 | Robotic living donor hepatectomy at University of Modena | Fabrizio Di Benedetto | Received |
eP-385 | Outcome of live liver donor who is 75 years old (case) | Geun Hong | Received |
eP-389 | Outcomes of LDLTs performed by the Georgian Liver Transplantation Center for 8 years | Kakhaber Kashibadze | Received |
eP-390 | Experiences and lessons learned from 427 living donors for liver transplantation | Kosei Takagi | Received |
eP-391 | FACTORS ASSOCIATED WITH EARLY VASCULAR COMPLICATIONS IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION | Ampaipan Boonthai | Received |
eP-392 | Single Dose Eculizumab as Desensitization Protocol For ABO-Incompatible Living Donor | Mario Spaggiari | Received |
eP-395 | Alteration of MELD score after plasmapheresis in ABO-incompatible living donor liver transplantation | Sukyoung Her | Received |
eP-396 | How could we establish the laparoscopic donor hepatectomy at a small volume center?; Our early experiences | Tae-Seok Kim | Received |
eP-397 | Graft Hepatic Artery Thrombosis in Living Donor Liver Transplantation from a COVID-19 Positive Donor | Vikram Raut | Received |
eP-398 | Ciliated Hepatic Foregut Cyst in the Explanted Liver of a Patient with Cryptogenic Cirrhosis | Rasim Farajov | Received |
eP-399 | The new generation of adult-to-adult living donor liver transplantations: towards all grafts and recipients alive after 12-months of median follow-up | Stefano Di Sandro | Received |
eP-400 | Liver Transplantation for Alcohol related liver disease in the era of Acute on chronic liver failure | Dinesh Jothimani | Received |
eP-401 | Donor outcome related to middle hepatic vein-sparing policy for donor hepatectomy in living donor liver transplantation | Kun-Ming Chan | Received |
eP-402 | Extraanatomic anatomic jump graft using great saphenous vein | Yang-Seok Koh | Received |
eP-403 | The Changing Face of Hepatocellular Carcinoma In Children | Sergio Assia-Zamora | Received |
eP-404 | Similar long-term outcome achieved with live donor and split deceased donor left liver grafts in paediatric liver transplantation | John McCall | Received |
eP-405 | Validation of prognotic prediction of Early allograft dysfunction models on Small Grafts in Pediatric liver transplantation | Jasper Sandeep Rajasekar | Received |
eP-406 | Surveillance liver biopsy in paediatric living donor liver transplantation from young donors - How is east different from the west? | Neelam Mohan | Received |
eP-407 | Prognostic impact of concurrent portal vein thrombosis in pediatric late liver re-transplantation | Riccardo Cirelli | Received |
eP-410 | Auxiliary partial orthotopic liver transplantation for metabolic disease in children: single centre experience | Miriam Cortes-Cerisuelo | Received |
eP-412 | Paediatric domino-liver transplantation for maple syrup urine disease | Arianna Trizzino | Received |
eP-415 | Paediatric Intestinal Transplantation, Unique Indications And Surgical Innovations. Two Decade Experience In A Single Centre | Sergio Assia-Zamora | Received |
eP-416 | EHPVO in children under 2 years old. Diagnostic and treatment strategies, and their influence on outcome | Oleg Godik | Received |
eP-417 | First 550 paediatric liver transplants: Experience from high volume paediatric liver transplant program in India | Naresh Shanmugam | Received |
eP-420 | Deceased donor liver transplantation in pediatric patients: Experience at a single center in Japan performing mostly living donor liver transplantation | Yasuharu Onishi | Received |
eP-421 | Living-donor Liver Transplantation Using Segment 2 Monosegment and Reduced Left Lateral Grafts in Pediatric Cases. A Single-Center Experience | Remzi Emiroglu | Received |
eP-423 | Association of PELD score with perioperative and postoperative outcomes in pediatric liver transplantation | Pitthawat Julnipithawong | Received |
eP-426 | Pathologic and Immunophenotypic Characterization of Syncytial Giant Cell Variant of Pediatric Hepatocellular Carcinoma. A Distinct Subtype | Mukul Vij | Received |
eP-430 | Live Donor Liver Transplantation in an Infant with Pneumonia due to Active COVID-19 Infection | Zaza Iakobadze | Received |
eP-431 | Dual immune tolerance to both blood group antigen and donor graft: Case report | Soo Jin Na Choi | Received |
eP-432 | Large-for-size grafts in infant living donor liver transplantation - A mixed reality approach for preoperative planning | Zong Jie Koh | Received |
eP-433 | Trial in progress: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond Milan Criteria | Maen Abdelrahim | Received |
eP-435 | Improving Access and Continuity of Care by Televideo Services During the COVID-19 Pandemic | Sudha Kodali | Received |
eP-436 | Should liver transplantation be offered to resectable patients with perihilar cholangiocarcinoma? | Eduardo Fernandes | Received |
eP-438 | INCREASING PREVALENCE OF LIVER TRANSPLANT RECIPIENTS WITH A HISTORY OF PRIOR MALIGNANCY LACKS CLEAR ASSOCIATION WITH DE NOVO MALIGNANCY RISK | Kymberly Watt | Received |
eP-439 | Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria | Shohei Yoshiya | Received |
eP-441 | Entecavir versus tenofovir on the recurrence of hepatitis B virus related hepatocellular carcinoma after liver transplantation: a Korean nation-wide study | Hwa-Hee Koh | Received |
eP-442 | Nivolumab after Sorafenib failure in liver recipients with Hepatocellular carcinoma recurrence | Jieun Kwon | Received |
eP-443 | Implications of incidental hepatocholangiocarcinoma in the explant of patients undergoing liver transplantation | Muthukumarassamy Rajakannu | Received |
eP-444 | Radiologic Response of Hepatocellular Carcinoma to Single vs combination Locoregional therapy (Neoadjuvant Yttrium-90 and Y90Transarterial Chemoembolization) | Sudha Kodali | Received |
eP-445 | Salvage Living Donor Liver Transplantation for post resection HCC recurrence: Are outcomes comparable to upfront transplantation? | Prashant Bhangui | Received |
eP-447 | Iron secretion by hepatocyte exosomes via Rab27A drived ferroptosis of CD8 cells to promote post-transplant HCC recurrence | wang zhe | Received |
eP-448 | Trial in progress: Neoadjuvant Combination Therapy of Lenvatinib plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-Eligible Patients with Large Hepatocellular Carcinoma | Maen Abdelrahim | Received |
eP-451 | Recurrence and survival following liver transplantation for Hepatocellular carcinoma without routine radiological surveillance | Bobby VM Dasari | Received |
eP-452 | Comparative Next generation sequencing analysis of Normal, Cirrhotic, and HCC tissue samples A step closer to precision medicine | Subathra Radhakrishnan | Received |
eP-453 | Survival Outcomes in Patients undergoing Liver Transplantation for Primary Sclerosing Cholangitis (PSC) and Incidental Cholangiocarcinoma | Sarah Al-Shakhshir | Received |
eP-455 | Impact of Everolimus versus Mycophenolate Mofetil in Combination with Reduced Tacrolimus on Oncologic Outcome after Liver Transplantation for Hepatocellular Carcinoma | Eun-Ki Min | Received |
eP-456 | Liver transplantation for hepatocellular carcinoma: the role of histology to predict worse disease-free and overall survival in pathological Milan Out patients in a single-center experience | Daniele Ferraro | Received |
eP-460 | Tyrosine Kinase Inhibitors therapy for Hepatocellular Carcinoma in patients waiting for liver transplant: is it safe? | grazia conte | Received |
eP-462 | Reduced Effect of Immune Checkpoint Therapy On Liver Metastases with Oral Budesonide Treatment: Implications for The Transplant Allograft? | Kymberly Watt | Received |
eP-463 | Domino liver transplantation for unresectable colon cancer liver metastases from a donor with heterozygous familial hyperlipidemia: A case report | YUZURU SAMBOMMATSU | Received |
eP-464 | Very late recurrence of hepatocellular carcinoma after living donor liver transplantation: case report | Seong-Hwan Chang | Received |
eP-466 | Alpha-fetoprotein response after first transarterial chemoembolization (TACE) and complete pathologic response in patients with hepatocellular cancer | Maciej Krasnod&281;bski | Received |
eP-467 | The impact of applying UCSF criteria to patients underwent liver transplantation for hepatocellular carcinoma in a low volume center | Doojin Kim | Received |
eP-468 | A case report of combination treatment (Trans arterial radio embolisation and Stereotactic beam radiotherapy) for an advanced Hepatocellular carcinoma as a bridge to liver transplantation | Deepashree Thiruchunapalli | Received |
May 3-6 Rotterdam, Netherlands
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|